0001646606-16-000002.txt : 20160803 0001646606-16-000002.hdr.sgml : 20160803 20160803145214 ACCESSION NUMBER: 0001646606-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160803 DATE AS OF CHANGE: 20160803 EFFECTIVENESS DATE: 20160803 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ImmunoMolecular Therapeutics, LLC CENTRAL INDEX KEY: 0001646606 IRS NUMBER: 472787642 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-268258 FILM NUMBER: 161803488 BUSINESS ADDRESS: STREET 1: 12635 EAST MONTVIEW BOULEVARD CITY: AURORA STATE: CO ZIP: 80045 BUSINESS PHONE: (303) 544-2104 MAIL ADDRESS: STREET 1: 12635 EAST MONTVIEW BOULEVARD CITY: AURORA STATE: CO ZIP: 80045 D 1 primary_doc.xml X0707 D LIVE 0001646606 ImmunoMolecular Therapeutics, LLC 12635 EAST MONTVIEW BOULEVARD AURORA CO COLORADO 80045 (303) 544-2104 DELAWARE None None Limited Liability Company true 2015 Steve Orndorff 12635 East Montview Boulevard Aurora CO COLORADO 80045 Executive Officer Director Promoter Peter Gottlieb 12635 East Montview Boulevard Aurora CO COLORADO 80045 Director Promoter Ed Orr 12635 East Montview Boulevard Aurora CO COLORADO 80045 Director Promoter Aaron Michels 12635 East Montview Boulevard Aurora CO COLORADO 80045 Promoter Biotechnology Decline to Disclose 06b false 2016-07-15 false true true Convertible promissory notes convertible into equity securities of the Issuer and the equity securities to be acquired upon such conversion false 0 3000000 350000 2650000 false 1 0 0 0 false ImmunoMolecular Therapeutics, LLC Steve Orndorff Steve Orndorff President and Chief Executive Officer 2016-08-03